Age-Related Changes in Pharmacokinetics: The Body’s Handling of Drugs
Pharmacokinetics describes how the body absorbs, distributes, metabolizes, and excretes a drug. With age, physiological changes alter each of these processes, leading to significant implications for medication administration and safety.
Absorption
Changes in the gastrointestinal system, such as decreased gastric acidity, slowed gastric emptying, and reduced splanchnic blood flow, can affect drug absorption, potentially altering the timing and rate of absorption for some medications.
Distribution
Age-related shifts in body composition significantly alter how drugs are distributed. Increased body fat and decreased total body water can lead to a larger volume of distribution for lipid-soluble drugs and a smaller volume of distribution for water-soluble drugs, impacting drug half-life and plasma concentrations. Decreased serum albumin can also result in a higher free fraction of highly protein-bound drugs, increasing the risk of adverse effects.
Metabolism
Drug metabolism primarily occurs in the liver. Reduced hepatic blood flow and altered enzyme activity, particularly in Phase I oxidation, can decrease the metabolism and clearance of certain drugs. Phase II conjugation reactions tend to be less affected by age.
Excretion
Kidney function naturally declines with age, significantly influencing drug excretion. A decreased Glomerular Filtration Rate (GFR) reduces the kidneys’ ability to filter drugs, potentially causing renally excreted medications to accumulate to toxic levels. Creatinine clearance is a more accurate indicator of renal function in older adults than serum creatinine alone due to reduced muscle mass.
Impact of Pharmacodynamic Changes
Pharmacodynamics, how a drug affects the body, also changes with age. Older adults may experience increased sensitivity to certain drugs, particularly those acting on the central nervous system, raising the risk of side effects like sedation and confusion. Alterations in drug receptor function can also affect drug effectiveness or increase side effect risks.
Comparison of Pharmacokinetic Changes by Drug Solubility
| Feature | Water-Soluble (Hydrophilic) Drugs | Lipid-Soluble (Lipophilic) Drugs |
|---|---|---|
| Effect of Age-Related Change | Reduced total body water leads to a smaller volume of distribution (Vd). | Increased body fat leads to a larger volume of distribution (Vd). |
| Plasma Concentration | Higher plasma concentrations for a given dose due to smaller Vd. | Potential for accumulation in fat stores, leading to erratic release and variable plasma levels. |
| Half-Life | Elimination half-life may be prolonged due to reduced renal clearance. | Elimination half-life is often significantly prolonged due to fat accumulation and slower release. |
| Risk Factor | Higher risk of acute toxicity, especially with narrow therapeutic index drugs. | Higher risk of chronic toxicity due to drug accumulation over time. |
| Clinical Example | Digoxin, Lithium, Aminoglycosides. | Diazepam, Amitriptyline. |
Best Practices for Clinicians and Caregivers
Given these physiological changes, it is essential to tailor medication management for older adults, often employing a "start low and go slow" approach to dosing and careful monitoring. Addressing adherence challenges is also important.
Conclusion
Aging affects how the body handles medications at every stage. Declining organ function, changes in body composition, and altered drug sensitivity necessitate a personalized approach to medication administration to optimize benefits and minimize harm in geriatric care. Continuous assessment and communication are key to safe and effective drug regimens as individuals age.
For more detailed guidance on medication safety in older adults, the National Institute on Aging provides additional resources.